Access to Birth Control Act
- Sponsor
- Sen. Booker, Cory A. [D-NJ]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- Aug 1, 2025
Bottom line
The Access to Birth Control Act aims to ensure timely and non-discriminatory access to contraception at pharmacies nationwide by establishing federal duties and enforcement mechanisms, while limiting the scope of refusal based on personal beliefs.
What it actually does
This bill amends the Public Health Service Act to mandate that pharmacies provide FDA-approved contraception and related medication without delay, or offer expedited alternatives if out of stock. It prohibits employees from interfering with access, misrepresenting information, or breaching confidentiality. The bill also specifies limited circumstances under which a pharmacy may refuse service, such as lack of a valid prescription or inability to pay, and clarifies that refusals based on professional clinical judgment must align with prevailing medical standards. It establishes civil penalties for violations and a private right of action for aggrieved individuals.
Proponents argue
Proponents argue that access to contraception is a fundamental right and essential healthcare, crucial for reproductive autonomy, educational, professional, and social aspirations, and for managing various medical conditions. They highlight systemic barriers, including discrimination and pharmacist refusals, which disproportionately affect marginalized communities. This bill would codify protections, ensuring consistent access to FDA-approved methods, including emergency and over-the-counter contraception, especially in the wake of increased denials following recent Supreme Court decisions.
Opponents contend
Opponents contend that the bill infringes upon the religious freedom and conscience rights of pharmacists and pharmacy owners, forcing them to participate in practices that conflict with their deeply held beliefs. They argue that existing state laws and professional standards are sufficient and that this federal mandate oversteps by limiting the exercise of professional judgment and religious liberty, potentially leading to legal challenges under the Religious Freedom Restoration Act.
The bill is concise and straightforward, allowing for a quick read and clear understanding of its core provisions within the time typically allotted for legislative review.
Section 3, Subsection (a)(1)
Duty to Provide In-Stock Contraception Without Delay
This provision requires pharmacies that stock FDA-approved contraception or related medication to provide it to a customer without delay if it is in stock. 'Without delay' is defined as within the usual and customary timeframe for providing other products at that pharmacy. This ensures immediate access to available contraceptive methods.
Supporters argue
Supporters argue this provision directly addresses instances of refusal and delay, ensuring that individuals can obtain essential medication promptly, which is particularly critical for time-sensitive contraception like emergency birth control. It removes a significant barrier to care.
Critics contend
Critics may argue that this provision, when combined with other elements of the bill, could force pharmacies or individual pharmacists to act against their conscience, even if the item is in stock, by removing discretion in certain situations.
Tradeoffs
This provision balances the immediate healthcare needs of individuals seeking contraception against potential claims of professional autonomy or religious freedom for pharmacists. It prioritizes timely access to medication.
Section 3, Subsection (a)(2)
Duties for Out-of-Stock Contraception
If a pharmacy normally stocks contraception but is currently out of a requested item, this provision mandates that the pharmacy immediately inform the customer and offer two options: either locate another pharmacy with the item in stock and refer/transfer the prescription, or order the item for expedited delivery and notify the customer upon arrival. This ensures customers are not left without options when an item is unavailable.
Section 3, Subsection (a)(3)
Prohibited Employee Actions
This subsection outlines specific actions that pharmacy employees are prohibited from taking regarding contraception requests. These include intimidating, threatening, or harassing customers; interfering with service delivery; intentionally misrepresenting availability or mechanism of action; breaching medical confidentiality; or refusing to return a valid prescription upon request. This aims to create a supportive and non-discriminatory environment for customers.
Section 3, Subsection (c)
Permissible Refusals Based on Standard Pharmacy Practice
This subsection clarifies that pharmacies are not prohibited from refusing to provide contraception under specific, limited circumstances. These include situations where a valid, lawful prescription is required but not presented, the customer cannot pay, or an employee refuses based on 'professional clinical judgment' in accordance with prevailing medical standards. This carves out legitimate reasons for refusal that are consistent with general pharmacy practice.
Section 3, Subsection (d)(2)
Religious Freedom Restoration Act (RFRA) Limitation
This provision states that the Religious Freedom Restoration Act of 1993 (RFRA) cannot be used to make a claim, defense, or challenge against the application or enforcement of the duties established in this bill. This aims to prevent RFRA from being invoked to justify refusals to provide contraception based on religious objections.
Section 3, Subsection (f)
Enforcement Mechanisms
This subsection establishes two primary mechanisms for enforcing the bill's requirements. First, pharmacies violating the duties can face a civil penalty of up to $1,000 per day of violation, with a maximum of $100,000 per single proceeding. Second, any person aggrieved by a violation can bring a private civil action in court to seek relief, including actual and punitive damages, injunctive relief, and attorney's fees. Both actions have a 5-year statute of limitations.
Defines 'professional clinical judgment' as 'the use of professional knowledge and skills to form a clinical judgment, in accordance with prevailing medical standards.'
Section 3, Subsection (g)(6)
Why it matters:This is standard legislative practice to consolidate definitions. However, its specific wording is crucial for understanding the scope of permissible refusals, as it significantly narrows what might otherwise be interpreted as a broad 'conscience clause.'
Case for: Proponents argue that this definition is essential to prevent subjective, non-medical reasons from being disguised as 'professional judgment.' It ensures that any refusal is based on established medical science and ethical standards, not personal beliefs, thereby safeguarding patient access.
Case against: Opponents contend that by tying 'professional clinical judgment' strictly to 'prevailing medical standards,' the bill effectively eliminates any room for pharmacists to exercise conscientious objection based on moral or religious beliefs, even if those beliefs do not contradict medical efficacy.
Estimated impact: This definition has a high impact on how the 'professional clinical judgment' exception (Subsection (c)(3)) will be interpreted and applied, significantly limiting its scope to medical rather than moral considerations.
Defines 'without delay' as 'within the usual and customary timeframe at the pharmacy for providing, providing a referral for, or ordering other products, or transferring the prescription for other products, respectively.'
Section 3, Subsection (g)(7)
Why it matters:This is standard legislative practice for definitions. However, the precise wording is critical for practical implementation, as it sets a clear, measurable standard for timeliness, preventing pharmacies from intentionally slowing down contraception access.
Case for: Proponents argue this definition provides a clear, objective standard for compliance, preventing pharmacies from creating artificial delays for contraception while serving other customers promptly. It ensures equitable service.
Case against: Opponents might argue that this definition, while seemingly neutral, could still be challenging to enforce consistently across diverse pharmacy settings and product types, potentially leading to disputes over what constitutes 'usual and customary timeframe.'
Estimated impact: This definition has a moderate impact on the day-to-day operations of pharmacies and the experience of customers, ensuring that contraception is handled with the same urgency as other medications.